Evidence map›Paper›PMID 42385012›Full record

ArticleCadernos de saude publica2026

[Disease, social, and economic burden of smoking in Brazil and the impact of tax increases on the economy and on the reduction of morbidity and mortality].

Márcia Pinto, Ariel Bardach, Agustín Casarini, Federico Augustovski, Alfredo Palacios, Natalia Espinola, Marcia Gisele Santos, Kátia Marie Simões E Senna, Ana Clara de Moraes, Vera Luiza da Costa E Silva and 4 more

Abstract readEnglish Abstract
In one paragraph

Article in Cadernos de saude publica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Márcia PintoInstituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira, Fundação Oswaldo Cruz, Rio de Janeiro, Brasil.ORCID http://orcid.org/0000-0001-7568-5014
Ariel BardachInstituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0003-4437-0073
Agustín CasariniInstituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0003-4952-0691
Federico AugustovskiInstituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0002-2914-5022
Alfredo PalaciosInstituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0001-7684-0880
Natalia EspinolaInstituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0001-5511-3561
Marcia Gisele SantosInstituto Nacional de Cardiologia, Rio de Janeiro, Brasil.ORCID http://orcid.org/0000-0003-3861-5257
Kátia Marie Simões E SennaInstituto Nacional de Cardiologia, Rio de Janeiro, Brasil.ORCID http://orcid.org/0000-0002-3583-2072
Ana Clara de MoraesUniversidade Federal de Juiz de Fora, Juiz de Fora, Brasil.ORCID http://orcid.org/0009-0003-4552-4924
Vera Luiza da Costa E SilvaSecretaria-Executiva da Comissão Nacional para Implementação da Convenção-Quadro para o Controle do Tabaco, Instituto Nacional de Câncer, Rio de Janeiro, Brasil.ORCID http://orcid.org/0000-0002-5608-7497
Felipe MendesSecretaria-Executiva da Comissão Nacional para Implementação da Convenção-Quadro para o Controle do Tabaco, Instituto Nacional de Câncer, Rio de Janeiro, Brasil.ORCID http://orcid.org/0000-0003-1071-1597
Cristiane Galhardo Ferreira ViannaSecretaria-Executiva da Comissão Nacional para Implementação da Convenção-Quadro para o Controle do Tabaco, Instituto Nacional de Câncer, Rio de Janeiro, Brasil.ORCID http://orcid.org/0009-0002-7057-2357
Ana Paula Leal TeixeiraSecretaria-Executiva da Comissão Nacional para Implementação da Convenção-Quadro para o Controle do Tabaco, Instituto Nacional de Câncer, Rio de Janeiro, Brasil.ORCID http://orcid.org/0000-0002-7400-8852
Andres Pichon-RiviereInstituto de Efectividad Clínica y Sanitaria, Buenos Aires, Argentina.ORCID http://orcid.org/0000-0001-6052-025X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to estimate the disease, social, and economic burden of smoking in Brazil in 2022 and to predict the benefits of tax increases, including its effects of the illegal market. A probabilistic Markov microsimulation model was applied in which individuals aged 35 years or older were followed in hypothetical cohorts and quantified deaths, health events, the direct cost of medical care, and the indirect cost due to productivity losses. A model to estimate health and economic gains from 10-year tax increase scenarios was developed. Data on smoking prevalence, the Brazilian demographic structure, mortality, and morbidity were obtained from official databases and the literature. The used health resources were obtained from the literature and consultations with specialists. Smoking caused 174,000 deaths and 5.7 million years of life lost due to premature death and disability. Its economic burden totaled BRL 153 billion, of which BRL 67 billion was attributed to direct costs and BRL 45 billion to indirect costs. The cost of informal caregivers equaled BRL 41 billion. In the scenario with the illegal market for tobacco products, a 50% increase in the price of cigarettes may generate economic benefits of BRL 161 billion in 10 years. The current tax reform currently in Brazil may constitute a permanent pricing and tax policy.

Indexed as

Cost of IllnessSmokingTaxesAdultBrazilHealth Care CostsHumansPrevalenceSocioeconomic Factors

Identifiers

PMID42385012
PMCPMC13313698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.